NCT01743235 - Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems | Biotech Hunter

Enrollment

207

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

Hypoactive Sexual Desire Disorder

Interventions

DRUG

Placebo

Solid Oral Dosage. Maximum every other day (on an as needed basis)

DRUG

Testosterone

Solid Oral Dosage. Maximum every other day (on an as needed basis)

DRUG

Buspirone hydrochloride

Solid Oral Dosage. Maximum every other day (on an as needed basis)

Trial Locations (12)

Michael A. Werner, MD PC, Purchase

Philadelphia Clinical Research, LLC, Philadelphia

Annapolis Sexual Wellness Center, Annapolis

Maryland Prime Care Physicians, Stevensville

Center for Sexual Medicine at Sheppard Pratt, Townson

Compass Research, Orlando

Segal Insitute for Clinical Research, North Miami

Meridien Research, St. Petersburg

Meridien Research, Bradenton

San Diego Sexual Medicine, San Diego

Boston Clinical Trials, Boston

NECCR Fall River LLC, Fall River